| Followers | 842 |
| Posts | 122790 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Saturday, May 07, 2011 5:28:10 PM
[Updated for SEC filings through 4/28/11.]
The table entries below include both ordinary and restricted
shares and both vested and non-vested options.
*10b5-1 selling plan in effect.
Shares Options
Officers
*Craig Wheeler (CEO) 548,126 775,000
*G Venkataraman (SVP/R&D) 412,498 182,820
*John Bishop (SVP/Pharma) 99,642 132,828
*Richard Shea (CFO) 91,903 272,378
*Bruce Leicher (Gen Cnsl) 91,795 160,228
*James Roach (CMO) 70,966 228,428
Directors
John Clarke 77,123 126,000
Bruce Downey 0 45,000
Marsha Fanucci 0 126,000
Peter Hutt 67,863 131,000
Thomas Koestler 0 30,000
*Bennett Shapiro 7,000 132,450
*Elizabeth Stoner 5,100 64,200
James Sulat 7,000 53,000
======================== ========= =========
All thirteen insiders 1,479,016 2,459,332
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
